These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1081 related articles for article (PubMed ID: 17302591)
1. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Barocci S; Valente U; Nocera A Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591 [TBL] [Abstract][Full Text] [Related]
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
3. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458 [TBL] [Abstract][Full Text] [Related]
4. Anti-HLA antibody profile of Turkish patients with end-stage renal disease. Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361 [TBL] [Abstract][Full Text] [Related]
5. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094 [TBL] [Abstract][Full Text] [Related]
6. Detection and specification of noncomplement binding anti-HLA alloantibodies. Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679 [TBL] [Abstract][Full Text] [Related]
7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
8. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants. Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806 [TBL] [Abstract][Full Text] [Related]
9. Algorithm to manage highly sensitized kidney transplant recipients in Poland. Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation. Michelon T; Schroeder R; Fagundes I; Canabarro R; Sporleder H; Rodrigues H; Silveira J; Montagner J; Garcia V; Neumann J; Graudenz M Transplant Proc; 2005; 37(6):2750-2. PubMed ID: 16182800 [TBL] [Abstract][Full Text] [Related]
11. [Anti-HLA antibodies in nephropathic patients]. Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900 [TBL] [Abstract][Full Text] [Related]
12. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival. Wu HH; Tien YC; Huang CI; Chiang YJ; Chu SH; Lai PC Transplant Proc; 2008 Sep; 40(7):2191-4. PubMed ID: 18790188 [TBL] [Abstract][Full Text] [Related]
13. Anti-HLA class II antibodies in kidney retransplant patients. Arnold ML; Pei R; Spriewald B; Wassmuth R Tissue Antigens; 2005 Apr; 65(4):370-8. PubMed ID: 15787721 [TBL] [Abstract][Full Text] [Related]
14. Alloantibodies and the outcome of cadaver kidney allografts. Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates. Arnold ML; Dechant M; Doxiadis II; Spriewald BM Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575 [TBL] [Abstract][Full Text] [Related]
16. Multi-array antibody screening in detecting antibodies to mismatched HLA in patients awaiting a second transplant. Rosenberg JC; Berri R; Jackowski M; Levis D; Nehlsen-Cannarella S; Oh H Transplant Proc; 2006 Dec; 38(10):3393-5. PubMed ID: 17175281 [TBL] [Abstract][Full Text] [Related]
17. Analysis of HLA class I specific antibodies in patients with failed allografts. Mao Q; Terasaki PI; Cai J; El-Awar N; Rebellato L Transplantation; 2007 Jan; 83(1):54-61. PubMed ID: 17220791 [TBL] [Abstract][Full Text] [Related]
18. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890 [TBL] [Abstract][Full Text] [Related]
19. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status. Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456 [TBL] [Abstract][Full Text] [Related]
20. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]